Hankyel Park

Array ( [id] => 3781129 [patent_doc_number] => 05840298 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof' [patent_app_type] => 1 [patent_app_number] => 8/634223 [patent_app_country] => US [patent_app_date] => 1996-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 19 [patent_no_of_words] => 21823 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840298.pdf [firstpage_image] =>[orig_patent_app_number] => 634223 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3931193 [patent_doc_number] => 05972511 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Process for forming low thermal expansion pyrolytic nitride coatings on low thermal expansion materials and coated article' [patent_app_type] => 1 [patent_app_number] => 8/630041 [patent_app_country] => US [patent_app_date] => 1996-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4632 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 223 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972511.pdf [firstpage_image] =>[orig_patent_app_number] => 630041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4002590 [patent_doc_number] => 05961984 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Human T-cell lymphotropic virus type I envelope protein and human monoclonal antibodies specific therefor' [patent_app_type] => 1 [patent_app_number] => 8/626452 [patent_app_country] => US [patent_app_date] => 1996-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12383 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/961/05961984.pdf [firstpage_image] =>[orig_patent_app_number] => 626452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3785590 [patent_doc_number] => 05840581 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Process for somatic embryogenesis of sweetgum' [patent_app_type] => 1 [patent_app_number] => 8/626235 [patent_app_country] => US [patent_app_date] => 1996-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 3792 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840581.pdf [firstpage_image] =>[orig_patent_app_number] => 626235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4098676 [patent_doc_number] => 06096869 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Treatment of papillomavirus-associated lesions' [patent_app_type] => 1 [patent_app_number] => 8/621841 [patent_app_country] => US [patent_app_date] => 1996-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10223 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096869.pdf [firstpage_image] =>[orig_patent_app_number] => 621841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4013070 [patent_doc_number] => 05962635 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Therapeutic compounds' [patent_app_type] => 1 [patent_app_number] => 8/553271 [patent_app_country] => US [patent_app_date] => 1996-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 17124 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962635.pdf [firstpage_image] =>[orig_patent_app_number] => 553271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1095753 [patent_doc_number] => 06821778 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-23 [patent_title] => 'Methods for using dendritic cells to activate gamma/delta-T cell receptor-positive T cells' [patent_app_type] => B1 [patent_app_number] => 08/610195 [patent_app_country] => US [patent_app_date] => 1996-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 9623 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/821/06821778.pdf [firstpage_image] =>[orig_patent_app_number] => 08610195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4015235 [patent_doc_number] => 05882404 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Powder coating apparatus' [patent_app_type] => 1 [patent_app_number] => 8/607098 [patent_app_country] => US [patent_app_date] => 1996-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3034 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/882/05882404.pdf [firstpage_image] =>[orig_patent_app_number] => 607098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4232749 [patent_doc_number] => 06090391 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'Recombinant tryptophan mutants of influenza' [patent_app_type] => 1 [patent_app_number] => 8/604757 [patent_app_country] => US [patent_app_date] => 1996-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12428 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090391.pdf [firstpage_image] =>[orig_patent_app_number] => 604757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3756822 [patent_doc_number] => 05741492 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses' [patent_app_type] => 1 [patent_app_number] => 8/590288 [patent_app_country] => US [patent_app_date] => 1996-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14622 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741492.pdf [firstpage_image] =>[orig_patent_app_number] => 590288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3837716 [patent_doc_number] => 05744316 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-28 [patent_title] => 'Isolated, tyrosinase derived peptides and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/587391 [patent_app_country] => US [patent_app_date] => 1996-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 37 [patent_no_of_words] => 9092 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/744/05744316.pdf [firstpage_image] =>[orig_patent_app_number] => 587391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4032465 [patent_doc_number] => 05942390 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-24 [patent_title] => 'Method of diagnosing predisposition for ulcerative colitis in Jewish population by detection of interleukin-1 receptor antagonist polymorphism' [patent_app_type] => 1 [patent_app_number] => 8/587911 [patent_app_country] => US [patent_app_date] => 1996-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4628 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/942/05942390.pdf [firstpage_image] =>[orig_patent_app_number] => 587911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3757602 [patent_doc_number] => 05843688 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Isolated tyrosinase derived peptides and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/583238 [patent_app_country] => US [patent_app_date] => 1996-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 30 [patent_no_of_words] => 6949 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843688.pdf [firstpage_image] =>[orig_patent_app_number] => 583238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998940 [patent_doc_number] => 05858723 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Polypeptides and antibodies for diagnosing and treating seminoma' [patent_app_type] => 1 [patent_app_number] => 8/567336 [patent_app_country] => US [patent_app_date] => 1995-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 12048 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858723.pdf [firstpage_image] =>[orig_patent_app_number] => 567336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3757587 [patent_doc_number] => 05843687 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Isolated, tyrosinase derived peptides and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/545212 [patent_app_country] => US [patent_app_date] => 1995-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 35 [patent_no_of_words] => 7818 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843687.pdf [firstpage_image] =>[orig_patent_app_number] => 545212 [rel_patent_id] =>[rel_patent_doc_number] =>)